UPDATE 1-Regeneron revenue beats Street on strong Eylea sales

... of the eye, and in July was approved to treat a related sight-robbing condition called diabetic macular edema. Tarrytown, New York-based Regeneron said it expected net sales of Eylea to be 25 percent to 30 percent higher this year than in 2014, when ...

http://ift.tt/1z46Tzj